At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 77 enrolled
Drug / intervention
metronidazole 1% gel +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Split-Face Tolerability Comparison Between MetroGel® (Metronidazole Gel) 1% vs Finacea® (Azelaic Acid) 15% in Subjects With Healthy Skin
In Brief
A Phase 4 clinical trial evaluating metronidazole 1% gel and azelaic acid 15% gel for Skin Manifestations. Completed, enrolled 77 participants across 1 site.
Detailed Summary
The purpose of this study is to compare the tolerability of MetroGel® 1% to Finacea® 15% in subjects with healthy skin applied according to product labeling for three weeks.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Manifestations
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
Enrollment StartJun 2010
Primary CompletionJun 2010
First PostedJun 2010
TodayJul 2026
First PostedJun 8, 2010
Enrollment StartJun 1, 2010
Primary CompletionJun 1, 2010
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 16.1 years ago
Interventions
metronidazole 1% geldrug
Apply topically once daily on one side of the face for three weeks
azelaic acid 15% geldrug
Apply topically twice daily on the opposite side of the face for three weeks